Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis

Rheumatology (Oxford). 2019 Jun 1;58(6):933-934. doi: 10.1093/rheumatology/key302.

Authors

Iris Navarro-Millán^{1

2}, Parag Goyal^{1

3}, Monika M Safford¹

Affiliations

¹ Department of Medicine, Division of General Internal Medicine, Weill Cornell Medicine, NY, USA.
² Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, NY, USA.
³ Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / blood
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy*
Cardiovascular Diseases / etiology
Cardiovascular Diseases / prevention & control*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Lipids / blood*
Practice Guidelines as Topic

Substances

Antirheumatic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids

Grants and funding